BKYI BIO key International Inc

BIO-key(R) Introduces Adaptive Multifactor Authentication WEB-key 3.5

Supports Biometric, Prox Cards & Challenge Response Questions

WALL, NJ--(Marketwired - May 8, 2014) - BIO-key International, Inc. (OTCQB: BKYI), a leader in fingerprint biometric identification technologies, cloud-based mobile credentialing and identity verification solutions, today reported that the company is introducing an adaptive multifactor authentication solution with its release of WEB-key 3.5.

WEB-key, leveraging BIO-key's NIST validated VST version 6.5 algorithm, is one of the most accurate fingerprint authentication solutions available today. WEB-key delivers a secure authentication framework; with session tracking and unique encryption for each transaction, utilizing structured interfaces and controls, leveraging BIO-key's patents for "System and Methods for Secure Biometric Authentication" and "Biometric Identification Network Security". WEB-key 3.5 supports biometric, prox cards and challenge response authentication modalities. New APIs in the WEB-key client allow for broader and easier use on Android, as well as enhanced security architecture for mobile environments.

"With the release of WEB-key 3.5, we address the growing demand for strong yet adaptive authentication methods across all verticals and essential mobile end points," stated Mira LaCous BIO-key's Chief Technology Officer. "Today, customers must consider issues such as interoperability to mobile, scalability for high demand and operation within many vendor based applications when building their security platforms. WEB-key 3.5 delivers unparalleled flexibility supporting multiple authentication methods across clients on laptops, tablets, and phones. The addition of BIO-key's ID Director product suite adds in the integration to Active Directory, as well as many enterprise vertical products such as IBM ISAM for Web, CA SiteMinder® and electronic healthcare record management systems including Epic, Allscripts, Caradigm and more. ID Director can also tie in additional authentication modes like One-Time-Pin (OTP) authentication systems."

LaCous added "Our healthcare customers in particular, need the ability to authenticate using multiple modalities, in order to meet two-factor compliance requirements. Adaptive authentication provides secure alternative authentication methods for non-biometric enabled endpoints to accommodate additional strong factors when required. This release also expands features of supported systems, including Linux servers and Android mobile clients, in addition to expanding on BIO-key's interoperability with the majority of fingerprint readers available today; allowing our customers to truly future-proof their authentication process."

About BIO-key BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)

BIO-key Safe Harbor Statement Certain statements contained in this press release are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, wider market acceptance of biometric technologies, our ability to raise additional financing, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2013 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to disclose any revision to these forward-looking statements whether to reflect events or circumstances after the date hereof or otherwise.

Investor & Media Contact: BIO-key International, Inc. Contact: Jay Meier Vice President Corporate Development Phone: 651-789-6116 Email: Jay.meier@bio-key.com